International Not-For-Profit Association "Smoking Control & Harm Reduction"

Tweet this page
Registration as it was on 04 Mar 2024
How to read and use this data card.
Download this datacard


Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

1.75 Fte (3)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    International Not-For-Profit Association "Smoking Control & Harm Reduction"   (S.Co.H.Re.)

    EU Transparency Register

    105924642733-12 First registered on 12 May 2021

    Goals / Remit

    • Our purpose is to provide stakeholders with science-based balanced information. Tobacco harm reduction debate is still at an early stage and more research and publications are needed.
    • We are working to better inform all stakeholders of the existing evidence corroborating that harm reduction in smoking should be implemented to counterfeit the detrimental effects of smoking, when smoking cessation fails or is not sought.
    • We are trying to raise awareness on existing knowledge, to benefit from already existing solid expertise in many countries, and to create more opportunities for education of health policy experts, regulators, and the public.
    • We will work to generate more evidence that harm reduction in smoking should be implemented along with smoking prevention and smoking cessation to counterfeit the detrimental effects of smoking.
    • We will establish new research to generate more evidence to cast out all doubt.

    Main EU files targeted

    • SCOHRE is an International scientific Association of independent experts on Smoking Control & Harm Reduction (established in September 2020 under the Belgian law), who seek an open and constructive dialogue to help come up with a new approach to smoking control policies.
    • We aspire to advocate for legislation change with regard to smoking control policies; to discuss with EU institutions the necessary steps for further research to create more data and evidence for legislation changes.
    • We, at SCOHRE, believe that smoking control strategies should be reshaped to include harm reduction through alternative potentially lower risk products use, besides the traditional smoking cessation and smoking prevention measures. Smoking results very often in diseases that put the life at risk e.g. cancer, cardiovascular disease, etc. and although smokers are aware of the risk, it is very difficult to quit smoking.Thus, we need to define new ways and interventions to minimise the effects of smoking. We, at SCOHRE, believe that harm reduction is an effective public health policy towards the right direction.
    • Smoking cessation and prevention remain the most impactful, cost-effective interventions in medicine, but there is an ongoing discussion that limiting the negative effects of smoking can be also achieved by tobacco harm reduction.
    • SCOHRE includes scientists from all sectors: basic science researchers, medical doctors, policy experts, behaviourists, legal experts, academics, and professionals, human rights advocates…
    • We need to work with EU institutions and come up with the right strategies to serve our major purpose, which is to protect the health of European citizens.


    Head Office
    Avenue Michel-Ange, numero 12
    Bruxelles 1000
    EU Office
    MINDVIEW 59, Mousson Street
    Athens GR 11524


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    21 founding members & 3 persons administrative work

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Non-governmental organisations, platforms and networks and similar

  • Networking


    Not available yet:
    We are not yet in membership status with other associations and organisations, however we are affiliated with other organisations sharing the same objectives, as stated in the section below.

    Member organisations

    Supporting Associations signing the Consensus (

    European Medical Association (EMA) – Manuel Pais-Clemente
    New Nicotine Alliance {Ireland} – Tom Gleeson
    Platform for the Reduction of Harm due to Tobacco Consumption {Spain} – Fernando Fernández Bueno
    Indonesian Tar Free Coalition (KABAR) {Indonesia} – Amaliya Amaliya
    DIRETA {Brazil} – Alexandro Lucian
    Tunisian Society of Tobaccology and Addictive Behaviors {Tunisia} – Fares Mili
    Associazione Nazionale Consumatori Vaporizzatori Personali (ANPVU) {Italia} – Carmine Canino
    Densaulyk Harm Reduction Association {Kazakhstan} – Gintautas-Yuozas Kentra
    Polish Society of Public Health {Poland} – Andrzej M. Fal
    New Nicotine Alliance {UK} – Louise Ross
    UKVIA {UK} – John Dunne
    Hungarian Scientific Association for Harm Reduction and Environmental Diseases {Hungary} – Emil Toldy-Schedel
    Quit for Good {Philippines} – Lorenzo Mata

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year


    Major funding types in closed year


    Funding types "other" information

    Major contributions in closed year

    None declared

    Other financial info

    With regards to the financial year results, we are in collaboration with an accounting office based in Brussels. The expenses so far are: - expensesfor the notary for the establishment of the AISBL (1,550 euros - sponsored by Mindview) - graphic design for the identity of the association &website construction (6,930 euros - sponsored by Mindview) - secretariat services (Mindview pro bono) Please note that Mindview is searching funding opportunities for SCOHRE in collaboration with organisations and universities from the EU (i.e. Horizon funding) and worlwide(philanthropists and bigger not-for-profit organisations), since SCOHRE does not accept funding from the tobacco industry. SCOHRE emergedfrom the 3rd Scientfic Summit on Tobacco Harm Reduction: Novel Products, Research & Policy in 2020, which was organised by Mindview,University of Thessaly (MSc in Toxicology), University of Patras (Laboratory of Molecular Biology and Immunology, School of Pharmacy),University of West Attica (Department of Public and Community Health) and University of Athens (Medical School, 2nd Cardiology Department,University Hospital Attikon). For more info visit event's website:
    During the 4th Summit, the declaration ofSCOHRE founding members was signed.

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)

    Artificial intelligence and digital#Cancer#Climate change, biodiversity and sustainable development#Competitive European Industry: long-term and sustainable investment#Disability

    Communication activities

    We will create:
    - Research projects to study effects of alternative and supplementary strategies to smoking cessation, tobacco harm reduction, and smoking initiation prevention.
    - Workshops, seminars, public awareness campaigns at European and national level.
    - Observational/behavioural studies at European level, including many countries for smoking and other addictions.
    - We will work closely with EU institutions and the industry to influence their methodologies of studying new, less harmful smoking products.
    We will publish all data and evidence originating in the above studies and projects. We will work also at national level in EU countries to advocate for unified legislation for smoking control.
    The focus is on the following key pillars:
    - Scientific evidence: sharing & publicising the latest scientific data, identifying research gaps & establishing research programmes, independently verifying industry data.
    - Behavioural scientific evidence: improve lives with behavioural science; focus on smokers: what are the needs of those who want to quit smoking; how to effectively help them to quit; how to effectively help those smokers who are not willing to quit.
    - Policy recommendations to provide options for all; those who wish to quit smoking, but have repeatedly failed; those who despite all are not willing to quit, but still have the right to a healthy life.

    Other activities

    None declared

  • Meetings


    None declared

Download this datacard